iShares U.S. Pharmaceuticals ETF (IHE) Holdings $68.92 -0.17 (-0.25%) (As of 11/1/2024 ET) Add Compare Share Share Holdings Stock AnalysisChartHeadlinesHoldingsOwnershipRatings Top 42 IHE HoldingsRankCompanyCurrent PriceWeightShares Held1JNJJohnson & Johnson$160.13+0.2%22.22%870,7252LLYEli Lilly and Company$818.93-1.3%22.07%155,8423BMYBristol-Myers Squibb$54.32-2.6%4.87%590,7094VTRSViatris$11.62+0.2%4.59%2,531,0985PFEPfizer$28.09-0.7%4.37%967,7206ZTSZoetis$181.95+1.8%4.31%151,073 Get the Latest News and Ratings for IHE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for iShares U.S. Pharmaceuticals ETF and its competitors with MarketBeat's FREE daily newsletter. 7CTLTCatalent$58.73+0.2%4.24%452,1198RPRXRoyalty Pharma$27.10+0.4%4.14%968,9029MRKMerck & Co., Inc.$101.88-0.4%4.13%250,22210ITCIIntra-Cellular Therapies$86.54+2.1%2.95%245,49911JAZZJazz Pharmaceuticals$110.45+0.4%2.68%154,27412ELANElanco Animal Health$12.60-0.3%2.43%1,234,90913OGNOrganon & Co.$18.07-3.8%1.75%643,21114CORTCorcept Therapeutics$47.62-2.8%1.74%232,32215AXSMAxsome Therapeutics$88.84-0.2%1.44%100,72616PBHPrestige Consumer Healthcare$74.05+0.4%1.43%123,80217PRGOPerrigo$26.09+1.8%1.36%340,78818EWTXEdgewise Therapeutics$34.00+1.3%0.81%145,24319LGNDLigand Pharmaceuticals$110.04+4.1%0.81%45,64020AMPHAmphastar Pharmaceuticals$50.73+0.4%0.76%94,84921SUPNSupernus Pharmaceuticals$33.97-0.3%0.74%137,66022ARVNArvinas$26.90+1.8%0.66%159,49123TARSTarsus Pharmaceuticals$47.30+6.3%0.54%86,48124AMRXAmneal Pharmaceuticals$8.49+0.2%0.49%370,11025SAVACassava Sciences$26.21+1.6%0.47%112,66426COLLCollegium Pharmaceutical$33.46-2.0%0.44%80,47427INVAInnoviva$19.26-1.5%0.43%137,53528HRMYHarmony Biosciences$33.08+3.0%0.41%75,25029NMRANeumora Therapeutics$11.17-2.4%0.40%207,88230ANIPANI Pharmaceuticals$58.19+1.7%0.38%41,44531ELVNEnliven Therapeutics$27.63-0.8%0.33%73,16532PCRXPacira BioSciences$16.57-0.2%0.31%115,23133PLRXPliant Therapeutics$14.52+3.2%0.30%133,66734PHATPhathom Pharmaceuticals$18.27+6.5%0.23%89,32335MNMDMind Medicine (MindMed)$6.14-2.5%0.18%182,73936RVNCRevance Therapeutics$5.80-1.7%0.17%223,73937NUVBNuvation Bio$2.30+4.1%0.15%421,45938TBPHTheravance Biopharma$8.28+0.5%0.12%87,20239BlackRock Cash Funds Treasury SL AgencyN/A0.10%614,29340USD CASHN/A0.04%248,341625,000% Gain (Ad)Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.>> Dive into the Workshop Here41CASH COLLATERAL USD SGAFTN/A0.01%45,00042E-MINI HEALTH CARE SECTOR DEC 24N/A0.00%6 Geographic ExposureUnited States95.7%Ireland4.1%Cayman Islands0.1%Currency ExposureUSD100.0%Sector ExposureHealth Care89.9%Energy0.4%Industry ExposureBiotechnology74.4%Pharmaceuticals6.6%Health Care Equipment & Supplies4.2%Renewable Energy0.4%SubIndustry ExposureBiotechnology71.3%Pharmaceuticals8.5%Health Care Equipment4.2%Renewable Energy Equipment0.4%Coupon Exposure0-299.9%4-60.1% Related Companies and Tools Related Companies VanEck Pharmaceutical ETF Portfolio iShares U.S. Healthcare Providers ETF Portfolio VanEck Biotech ETF Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio Direxion Daily S&P Biotech Bull 3x Shares Portfolio Invesco S&P 500 Equal Weight Health Care ETF Portfolio Invesco Pharmaceuticals ETF Portfolio Invesco Biotechnology & Genome ETF Portfolio SPDR S&P Health Care Equipment ETF Portfolio Invesco S&P SmallCap Health Care ETF Portfolio This page (NYSEARCA:IHE) was last updated on 11/2/2024 by MarketBeat.com Staff From Our PartnersMusk warns humanity: “Obsolete”The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | Sponsored625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares U.S. Pharmaceuticals ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares U.S. Pharmaceuticals ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
